Literature DB >> 21641391

Adiponectin regulation of stellate cell activation via PPARγ-dependent and -independent mechanisms.

Mahnoush S Shafiei1, Shoba Shetty, Philipp E Scherer, Don C Rockey.   

Abstract

In this study, we elucidated the mechanism by which adiponectin modulates hepatic stellate cell activation and fibrogenesis. Adiponectin-overexpressing transgenic mice receiving thioacetamide were resistant to fibrosis, compared with controls. In contrast, adiponectin-null animals developed severe fibrosis. Expression of collagen α1(I) and α-smooth muscle actin (α-SMA) mRNAs were significantly lower in adiponectin-overexpressing mice, compared with controls. In wild-type stellate cells exposed to a lentivirus encoding adiponectin, expression of peroxisome proliferator-activated receptor-γ (PPARγ), SREBP1c, and CEBPα mRNAs was significantly increased (3.2-, 4.1-, and 2.2-fold, respectively; n = 3; P < 0.05, adiponectin virus versus control), consistent with possible activation of an adipogenic transcriptional program. Troglitazone, a PPARγ agonist, strongly suppressed up-regulation of collagen α1(I) and α-SMA mRNA in stellate cells isolated from wild-type mice; however, stellate cells from adiponectin-null animals failed to respond to troglitazone. Furthermore, in isolated stellate cells in which PPARγ was depleted using an adenovirus-Cre-recombinase system and in which adiponectin was also overexpressed, collagen α1(I) and α-SMA were significantly inhibited. We conclude that the PPARγ effect on stellate cell activation and the fibrogenic cascade appears to be adiponectin-dependent; however, the inhibitory effect of adiponectin on stellate cell activation was not dependent on PPARγ, suggesting the presence of PPARγ-dependent as well as independent pathways in stellate cells.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21641391      PMCID: PMC3124230          DOI: 10.1016/j.ajpath.2011.02.035

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury.

Authors:  Mingyan Zhou; Aimin Xu; Paul K H Tam; Karen S L Lam; Lawrence Chan; Ruby L C Hoo; Jing Liu; Kim H M Chow; Yu Wang
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

2.  Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice.

Authors:  Alain Da Silva Morais; Jorge Abarca-Quinones; Yves Horsmans; Peter Stärkel; Isabelle A Leclercq
Journal:  Int J Mol Med       Date:  2007-01       Impact factor: 4.101

3.  Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference.

Authors:  Scott L Friedman; Don C Rockey; D Montgomery Bissell
Journal:  Hepatology       Date:  2007-01       Impact factor: 17.425

4.  Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.

Authors:  Masato Yoneda; Tomoyuki Iwasaki; Koji Fujita; Hiroyuki Kirikoshi; Masahiko Inamori; Yuichi Nozaki; Shiro Maeyama; Koichiro Wada; Satoru Saito; Yasuo Terauchi; Atsushi Nakajima
Journal:  Alcohol Clin Exp Res       Date:  2007-01       Impact factor: 3.455

Review 5.  Roles of adipokines in liver injury and fibrosis.

Authors:  Jianhua Wang; Joanne Brymora; Jacob George
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2008-02       Impact factor: 3.869

6.  Transplantation of basic fibroblast growth factor-pretreated adipose tissue-derived stromal cells enhances regression of liver fibrosis in mice.

Authors:  Yoshihiro Kamada; Yuichi Yoshida; Yukiko Saji; Juichi Fukushima; Shinji Tamura; Shinichi Kiso; Norio Hayashi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-04       Impact factor: 4.052

7.  Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing.

Authors:  D C Rockey; J J Chung
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

8.  Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin.

Authors:  Yoshihiro Kamada; Shinji Tamura; Shinichi Kiso; Hitoshi Matsumoto; Yukiko Saji; Yuichi Yoshida; Koji Fukui; Norikazu Maeda; Hitoshi Nishizawa; Hiroyuki Nagaretani; Yoshihisa Okamoto; Shinji Kihara; Jun-Ichiro Miyagawa; Yasuhisa Shinomura; Tohru Funahashi; Yuji Matsuzawa
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

9.  Pattern of expression of adiponectin receptors in human liver and its relation to nonalcoholic steatohepatitis.

Authors:  M Nannipieri; F Cecchetti; M Anselmino; E Mancini; G Marchetti; A Bonotti; S Baldi; B Solito; M Giannetti; A Pinchera; F Santini; E Ferrannini
Journal:  Obes Surg       Date:  2008-10-16       Impact factor: 4.129

10.  High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase.

Authors:  Masayuki Adachi; David A Brenner
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

View more
  25 in total

1.  Adiponectin and its Hydrolase-Activated Receptors.

Authors:  Ankit X Sharma; William L Holland
Journal:  J Nat Sci       Date:  2017-06

Review 2.  Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic β cells and adipocytes.

Authors:  Caroline Tao; Angelica Sifuentes; William L Holland
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-11-15       Impact factor: 4.690

Review 3.  Mechanisms of hepatic stellate cell activation.

Authors:  Takuma Tsuchida; Scott L Friedman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-10       Impact factor: 46.802

Review 4.  Fibrosis and adipose tissue dysfunction.

Authors:  Kai Sun; Joan Tordjman; Karine Clément; Philipp E Scherer
Journal:  Cell Metab       Date:  2013-08-15       Impact factor: 27.287

5.  Enhanced fatty acid flux triggered by adiponectin overexpression.

Authors:  Shoba Shetty; Maria A Ramos-Roman; You-Ree Cho; Jonathan Brown; Jorge Plutzky; Eric S Muise; Jay D Horton; Philipp E Scherer; Elizabeth J Parks
Journal:  Endocrinology       Date:  2011-11-01       Impact factor: 4.736

6.  Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver.

Authors:  Pil-Hoon Park; Carlos Sanz-Garcia; Laura E Nagy
Journal:  Curr Pathobiol Rep       Date:  2015-09-30

Review 7.  Fibrosis reversal after hepatitis C virus elimination.

Authors:  Don C Rockey
Journal:  Curr Opin Gastroenterol       Date:  2019-05       Impact factor: 3.287

Review 8.  Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies.

Authors:  Don C Rockey
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-07       Impact factor: 11.382

Review 9.  Metabolic Messengers: Adiponectin.

Authors:  Leon G Straub; Philipp E Scherer
Journal:  Nat Metab       Date:  2019-03-14

10.  The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy.

Authors:  Feng Fang; Lei Liu; Yang Yang; Zenshiro Tamaki; Jun Wei; Roberta G Marangoni; Swati Bhattacharyya; Ross S Summer; Boping Ye; John Varga
Journal:  Arthritis Res Ther       Date:  2012-10-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.